But combined with proper nutrition and exercise, these small benefits may add up over time
Do not stop GLP-1 medication without consulting your prescriber, as the underlying condition (diabetes or obesity) requires ongoing management
Singh B, Ronghe AM, Chatterjee A, Bhat NK, Bhat HK
Tirzepatide dosing should follow FDA-approved protocols: initiate at 2.5 mg subcutaneously once weekly for four weeks, then increase to 5 mg weekly
17 In a randomized controlled study of adults with overweight or obesity and traits of metabolic syndrome, fiber supplementation with energy restriction improved body weight, body mass index, fat mass, visceral fat, lipid profile, and inflammatory markers